Here’s Why Agios Pharmaceuticals Crashed 23% Today
Key Points Agios Pharmaceuticals shares dropped 23% following Novo Nordisk’s trial results. Novo’s etavopivat outperformed Agios’ mitapavit in…
Novo Nordisk Ups the Ante with Wegovy HD Rollout
In a significant development for the weight-loss drug market, Novo Nordisk has introduced a higher-dose version of…
Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 6-K ________________ REPORT…
Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 6-K ________________ REPORT…
Is Novo Nordisk’s Turnaround Story at Risk After Weak 2026 Outlook?
Novo Nordisk NVO announced better-than-expected fourth-quarter and full-year results last week. The company is a dominant player in the cardiometabolic…